26/01/2026
KEMSA - PFIZER DEAL EXPANDS ACCESS TO AFFORDABLE CANCER AND HEART MEDICINE
KEMSA CEO, Dr. Waqo Ejersa, accompanied by Director Commercial Services Eliud Muriithi, today met with the Pfizer team led by Vice President Ali Besri to advance discussions on rolling out an access program for oncology and cardiovascular products at significantly reduced prices.
The engagement leverages KEMSA’s strengthened end-to-end supply chain systems that have improved forecasting procurement efficiency and last-mile distribution ensuring critical medicines consistently reach health facilities and patients when they are needed most.
Through this partnership, patients will benefit from increased availability, improved affordability and uninterrupted access to life-saving therapies while strengthening long-term health outcomes.
The meeting also explored knowledge exchange and capacity building programs to further enhance local expertise and system resilience.